CID 36294
Tobramycin
Structural Information
- Molecular Formula
- C18H37N5O9
- SMILES
- C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)CN)O)N)N
- InChI
- InChI=1S/C18H37N5O9/c19-3-9-8(25)2-7(22)17(29-9)31-15-5(20)1-6(21)16(14(15)28)32-18-13(27)11(23)12(26)10(4-24)30-18/h5-18,24-28H,1-4,19-23H2/t5-,6+,7+,8-,9+,10+,11-,12+,13+,14-,15+,16-,17+,18+/m0/s1
- InChIKey
- NLVFBUXFDBBNBW-PBSUHMDJSA-N
- Compound name
- (2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol
- Related CIDs
2D Structure
Profile
Predicted Collision Cross Section
Adduct | m/z | Predicted CCS (Ų) |
---|---|---|
[M+H]+ | 468.26640 | 214.9 |
[M+Na]+ | 490.24834 | 214.6 |
[M+NH4]+ | 485.29294 | 214.8 |
[M+K]+ | 506.22228 | 215.2 |
[M-H]- | 466.25184 | 207.0 |
[M+Na-2H]- | 488.23379 | 230.1 |
[M]+ | 467.25857 | 212.7 |
[M]- | 467.25967 | 212.7 |